Tilray Brands (TLRY) Share-based Compensation (2017 - 2026)
Tilray Brands (TLRY) reported Share-based Compensation of $13.7 million for Q1 2026, up 240.15% on a YoY basis from $4.0 million in Q1 2025, and up 11.74% quarter-over-quarter from $12.3 million in Q4 2025.
Tilray Brands (TLRY) Share-based Compensation (2017 - 2026) Analysis & Trends
Tilray Brands has reported Share-based Compensation for 10 years, with the latest figure at $13.7 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 240.15% year-over-year to $13.7 million; the trailing twelve-month figure through Feb 2026 stood at $37.2 million (up 46.06% YoY), and the FY2025 full-year result was $24.3 million, down 23.54% from the prior year.
- Share-based Compensation for Q1 2026 stood at $13.7 million, up from $12.3 million in the prior quarter.
- The five-year high for Share-based Compensation was $13.7 million in Q1 2026, with the low at $4.0 million in Q1 2025.
- Historically, Share-based Compensation has averaged $8.5 million across 5 years, with a median of $8.3 million in 2023.
- Annual changes were most pronounced in 2025 — Share-based Compensation slumped 49.93% — and 2026, when it surged 240.15%.
- Tilray Brands' Share-based Compensation stood at $10.9 million in 2022, then fell by 25.06% to $8.2 million in 2023, then fell by 11.75% to $7.2 million in 2024, then jumped by 69.73% to $12.3 million in 2025, then increased by 11.74% to $13.7 million in 2026.
- The last three Share-based Compensation figures came in at $13.7 million (Q1 2026), $12.3 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 13.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 13.73 Mn |
| Feb 28, 2026 | 13.73 Mn |
| Nov 30, 2025 | 12.28 Mn |
| Nov 30, 2025 | 12.28 Mn |
| Aug 31, 2025 | 5.05 Mn |
| Aug 31, 2025 | 5.05 Mn |
| May 31, 2025 | 6.10 Mn |
| May 31, 2025 | 6.10 Mn |
| Feb 28, 2025 | 4.04 Mn |
| Feb 28, 2025 | 4.04 Mn |
| Nov 30, 2024 | 7.24 Mn |
| Nov 30, 2024 | 7.24 Mn |
| Aug 31, 2024 | 6.92 Mn |
| Aug 31, 2024 | 6.92 Mn |
| May 31, 2024 | 7.25 Mn |
| May 31, 2024 | 7.25 Mn |
| Feb 29, 2024 | 8.06 Mn |
| Feb 29, 2024 | 8.06 Mn |
| Nov 30, 2023 | 8.20 Mn |
| Nov 30, 2023 | 8.20 Mn |